{"id":2855,"date":"2026-08-21T14:26:07","date_gmt":"2026-08-21T13:26:07","guid":{"rendered":"https:\/\/seamlessbio.de\/?p=2855"},"modified":"2026-08-21T14:27:56","modified_gmt":"2026-08-21T13:27:56","slug":"off-the-clot-serum-explained","status":"publish","type":"post","link":"https:\/\/seamlessbio.de\/de\/off-the-clot-serum-explained\/","title":{"rendered":"Off-the-Clot (OTC) Serum Explained \u2014 When & Why to Use It"},"content":{"rendered":"

<\/p>\n

August 2026 \u00b7 6 min read<\/em><\/p>\n

If you have browsed human serum catalogues you have seen “off-the-clot” or “OTC” serum listed alongside standard serum at a slightly higher price. The difference is not just a collection method \u2014 it affects growth factor content, platelet protein release, and which applications the serum is suited for.<\/p>\n

What “off-the-clot” means<\/h2>\n

The distinction comes from how blood is collected and allowed to clot before serum separation.<\/p>\n

Standard (plasma-derived) serum:<\/strong> Blood is collected with an anticoagulant (heparin, citrate, or EDTA), preventing immediate clotting. The anticoagulated plasma is then processed by adding calcium chloride to trigger controlled, artificial clotting at a defined time and temperature. Platelets remain largely intact during this process \u2014 their intracellular contents (PDGF, EGF, TGF-\u03b2, serotonin, vWF) are not released. The result is a serum with a more defined, reproducible protein profile but lower growth factor concentration.<\/p>\n

Off-the-clot (OTC) serum:<\/strong> Blood is collected without anticoagulant and allowed to clot naturally at room temperature for 30\u201360 minutes. During natural clotting, thrombin activates platelets, which degranulate and release their full intracellular content into the clot and surrounding serum. When the clot is removed by centrifugation, the serum retains this dense growth factor payload \u2014 elevated PDGF-AB, PDGF-BB, EGF, TGF-\u03b21, FGF-2, VEGF, and serotonin compared to standard serum from the same donor pool.<\/p>\n

Growth factor comparison \u2014 OTC vs standard serum<\/h2>\n\n\n\n\n\n\n\n\n\n
Wachstumsfaktor<\/th>\nStandard (plasma-derived) serum<\/th>\nOff-the-clot serum<\/th>\nBiological role in cell culture<\/th>\n<\/tr>\n
PDGF-AB\/BB<\/td>\nLow (platelets intact)<\/td>\nHigh (full degranulation)<\/td>\nPrimary mitogen for fibroblasts, MSC, smooth muscle cells<\/td>\n<\/tr>\n
TGF-\u03b21<\/td>\nLow\u2013medium<\/td>\nHoch<\/td>\nProliferation, differentiation, immunomodulation<\/td>\n<\/tr>\n
EGF<\/td>\nNiedrig<\/td>\nMedium\u2013high<\/td>\nEpithelial and mesenchymal proliferation<\/td>\n<\/tr>\n
VEGF<\/td>\nNiedrig<\/td>\nMittel<\/td>\nEndothelial cell support<\/td>\n<\/tr>\n
Fibronectin<\/td>\nPresent (plasma source)<\/td>\nPresent + platelet-derived<\/td>\nCell attachment, migration<\/td>\n<\/tr>\n
Albumin<\/td>\n~40 mg\/mL<\/td>\n~40 mg\/mL<\/td>\nCarrier, osmotic balance \u2014 similar in both<\/td>\n<\/tr>\n
IgG<\/td>\n~8\u201312 mg\/mL<\/td>\n~8\u201312 mg\/mL<\/td>\nSimilar in both \u2014 consider for Protein A purification<\/td>\n<\/tr>\n<\/table>\n

When to use OTC serum<\/h2>\n

Cell culture requiring maximum growth support<\/h3>\n

For primary human cells \u2014 fibroblasts, keratinocytes, smooth muscle cells, endothelial cells \u2014 OTC serum provides superior mitogenic activity compared to standard serum at the same concentration, due to the PDGF and EGF content from platelet degranulation. If your primary cells proliferate slowly or inconsistently in standard human serum, switching to OTC is often the first thing to try before increasing concentration.<\/p>\n

Hybridoma cloning and expansion<\/h3>\n

OTC serum is the traditional choice for hybridoma culture. The platelet-derived growth factors (particularly PDGF) provide the mitogenic support that hybridomas \u2014 which are derived from B lymphocytes \u2014 require for efficient colony formation during limiting dilution cloning. OTC human serum at 10% is preferred over standard plasma-derived serum for hybridoma applications where human serum is used (noting the caveat that human IgG content co-purifies with murine mAb in Protein A columns \u2014 OTC is used only when Protein A purification is not the downstream step).<\/p>\n

Malaria parasite culture (P. falciparum)<\/h3>\n

Plasmodium falciparum culture requires human AB OTC serum as an essential supplement \u2014 the parasite depends on human serum components including specific lipids and growth factors that cannot be substituted with FBS. This is one of the few cell biology applications where OTC human serum is the only viable option, not an alternative.<\/p>\n

Wound healing and migration assays<\/h3>\n

For scratch assay chemoattraction gradients where serum-derived factors drive cell migration, OTC serum provides a stronger and more physiologically relevant migratory signal than standard serum due to its higher PDGF and EGF content.<\/p>\n

When NOT to use OTC serum<\/h2>\n

IVD calibrator and diagnostic matrix development<\/h3>\n

IVD assay development requires a serum matrix with a defined, reproducible protein profile that closely mimics the average patient sample. OTC serum lot-to-lot variation in platelet activation level (and therefore growth factor content) is higher than standard serum \u2014 this variability is a problem when you are trying to produce consistent calibrators. Standard plasma-derived serum is the correct choice for IVD applications.<\/p>\n

Cytokine assays and multiplex immunoassays<\/h3>\n

The elevated TGF-\u03b21 and serotonin in OTC serum can interfere with cytokine multiplex assays \u2014 particularly TGF-\u03b2 quantification, where OTC serum background can obscure biological signal from treated cells. Standard serum HI is preferred for cytokine assay matrix.<\/p>\n

Protein binding and plasma stability (DMPK)<\/h3>\n

Standard human AB serum is used for DMPK protein binding and plasma stability assays because the defined protein profile gives more consistent esterase activity measurements. OTC serum’s variable platelet content adds unwanted variability to these assays.<\/p>\n

Available from SeamlessBio<\/h2>\n

SeamlessBio supplies Human OTC Serum from EU and US donors \u2014 pooled mixed-gender AB, native and heat inactivated. Available in 100 mL and 500 mL. Batch reservation available for malaria culture programmes and hybridoma campaigns.<\/p>\n

\u2192 View Human Serum portfolio<\/a> | \u2192 Request test volumes<\/a><\/p>\n

Summary \u2014 three questions to decide<\/h2>\n
    \n
  1. Do you need maximum mitogenic activity?<\/strong> Yes \u2192 OTC serum<\/li>\n
  2. Do you need a defined, reproducible matrix for IVD or calibrators?<\/strong> Yes \u2192 standard serum<\/li>\n
  3. Is your application malaria culture or hybridoma?<\/strong> Yes \u2192 OTC serum specifically<\/li>\n<\/ol>\n
    \n

    Weiterf\u00fchrende Literatur:<\/strong><\/p>\n